Jodi B. Segal

发表

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

S. Vesely, J. George, L. Beebe, 2010, American journal of hematology/oncology.

Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists.

D. Moher, J. Segal, R. Kane, 2011, Journal of clinical epidemiology.

Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM–Coded Data Among Older Adults

J. Goodwin, G. Alexander, H. Mehta, 2022, Annals of Internal Medicine.

Changing patterns of use of implantable cardiac monitors from 2011 to 2018 for a large commercially-insured U.S. population

Nae-Yuh Wang, J. Marine, K. Andersen, 2021, Medicine.

BEHAVIORAL THERAPY AND SEROTONIN REUPTAKE INHIBITOR PHARMACOTHERAPY IN THE TREATMENT OF OBSESSIVE–COMPULSIVE DISORDER: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF HEAD‐TO‐HEAD RANDOMIZED CONTROLLED TRIALS

R. Romanelli, R. Mojtabai, Jodi B. Segal, 2014, Depression and anxiety.

Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM–Coded Data Among Older Adults

J. Goodwin, G. Alexander, H. Mehta, 2022, Annals of Internal Medicine.

Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis

J. Segal, A. Olivi, D. Gerber, 2007, Cancer.

Prevalence of primary immune thrombocytopenia in Oklahoma

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

Determining a definite diagnosis of primary immune thrombocytopenia by medical record review

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation study

Jodi B Segal, N. Powe, Neil R Powe, 2004, American journal of hematology.

Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative

C. Chute, J. Singh, M. Haendel, 2021, The Lancet Rheumatology.

Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes

D. Scharfstein, M. Rosenblum, I. Díaz, 2020, Biometrics.

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes

D. Scharfstein, M. Rosenblum, I. Díaz, 2020, medRxiv.

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Ordinal or Time to Event Outcomes

D. Scharfstein, M. Rosenblum, I. Díaz, 2020 .

Preliminary Competencies for Comparative Effectiveness Research

W. Kapoor, R. Filart, H. Selker, 2012, Clinical and translational science.

Assessing Heterogeneity of Treatment Effect in Real-World Data

R. Varadhan, James Heyward, F. Nyberg, 2023, Annals of Internal Medicine.

Assessing Heterogeneity of Treatment Effect in Real-World Data

Nicholas C. Henderson, R. Varadhan, James Heyward, 2023, Annals of Internal Medicine.

Brand versus generic: addressing non‐adherence, secular trends and non‐overlap

D. Scharfstein, Marissa J. Seamans, I. Murimi, 2019, Journal of the Royal Statistical Society: Series A (Statistics in Society).

Hospitalization rates and costs of care of patients with sickle‐cell anemia in the state of Maryland in the era of hydroxyurea

C. Haywood, G. Dover, S. Lanzkron, 2006, American journal of hematology.

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study

Brian L. Pearlman, A. Lok, D. Nelson, 2021, Hepatology.

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

S. Schneeweiss, M. Thambisetty, R. Desai, 2022, Brain communications.

Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents

S. Schneeweiss, M. Thambisetty, R. Desai, 2022, JAMA network open.

Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end‐stage kidney disease: A national cohort study

D. Brotman, M. Streiff, S. Deitelzweig, 2022, Journal of hospital medicine.

Prevalence of immune thrombocytopenia: analyses of administrative data

N. Powe, N. Powe, Jodi B. Segal, 2006, Journal of thrombosis and haemostasis : JTH.

Diagnosis of crystal-induced arthritis by synovial fluid examination for crystals: lessons from an imperfect test.

J. Segal, D. Albert, Jodi B. Segal, 1999, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes

D. Scharfstein, I. Díaz, D. Benkeser, 2020, medRxiv.

Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists.

D. Moher, M. Maglione, G. Raman, 2011, Journal of Clinical Epidemiology.

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

S. Vesely, J. George, L. Beebe, 2010, American journal of hematology.

Prevalence of primary immune thrombocytopenia in Oklahoma

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

Strategies To Prevent Weight Gain in Adults: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 97

C. Boult, B. Lau, K. Gudzune, 2013 .

Construction of a Multisite DataLink Using Electronic Health Records for the Identification, Surveillance, Prevention, and Management of Diabetes Mellitus: The SUPREME-DM Project

Jay R. Desai, Christina L. Clarke, R. Pathak, 2012, Preventing chronic disease.

Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection.

D. Chan, J. Segal, R. Hruban, 2001, Clinica chimica acta; international journal of clinical chemistry.